Back to search results

Web-based Support for Breast Cancer Pain Management

This study is testing two web-based programs, CAI and CAPA, designed to help manage cancer pain. These programs offer information, coaching, and support. The study is looking for women aged 18 or older who have had breast cancer, identify as Chinese, Korean, or Japanese, and have experienced cancer pain recently. You should also be able to read English, Mandarin, Korean, or Japanese and have internet access. The researchers want to see if these programs can improve how pain is managed and reduce pain levels over three months. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 300 participants. It compares two behavioral web-app interventions for cancer pain management.
What's involved
Your pain management will be measured at the start of the study, after 1 month, and after 3 months. You will also use an activity monitoring device (Fitbit) during these periods.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after starting the intervention, with measurements taken at 1 and 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06085313

Cancer Pain Management Using a Web-based Intervention

Recruiting
NAAges 18+InterventionalTreatment
University of Texas at Austin
~300 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:CAICAPA

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cancer Pain Management (CPM)
Measured over Pretest, Post 1-month, Post 3-months
+5 more outcomes measured

Conditions

Cancer of Breast
Depressive Symptoms
Cancer Pain

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Eun Ok Im · PRINCIPAL_INVESTIGATOR · The University of Texas at Austin

Who to contact

Wonshik Chee
[email protected]
512-232-2142
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

women aged 18 years and older who identify as Chinese, Korean, or Japanese;
have had a breast cancer diagnosis in the past;
can read and write English, Mandarin (simplified or traditional), Korean, or Japanese;
have access to the internet through computers or mobile devices (mobile phones and tablets);
have experienced cancer pain during the past week (at least 1 on a scale from 0 to 5 \[no symptom=0, mild symptom that does not bother=1, somewhat bothering symptom=2, moderate symptom=3, severe symptom=4, and worst possible symptom=5\]);
have experienced depressive symptoms during the past two weeks (1 to 10 on the Patient Health Questionnaire) which is equivalent to the cut-point of minimal to moderate depression.

Exclusion

less than 18 years old because their cancer experience would be different from that of adults.
Those who are in treatment or not in treatment, but who were diagnosed with breast cancer within the past five years, will be excluded.
Those who participated in the PI's pilot studies will be excluded.
The participants of R33 phase will exclude those in active depression treatment regardless of their level of depression.
Those without Internet access will be excluded, but those with Internet access through community/group computers will be included.

What this trial measures

  • Cancer Pain Management (CPM)Pretest, Post 1-month, Post 3-months

    1 yes/no question on if cancer pain is managed. If yes, additional questions on cancer pain management (types \[e.g., acetaminophen, NSAIDs, opioid, massage, acupuncture, acupressure, etc.\] and frequency of management \& how much relief). If no, what are the reasons.

  • Brief Pain Inventory-Short Form (BPI-SF)Pretest, Post 1-month, Post 3-months

    15 items: (a) a global yes or no item asking for a comparison of pain with other minor aches/pains; (b) 4 items (0\~10) for the sensory component; (c) 1 item for pain medications; (d) a numerical scale rating the effectiveness of pain relief; (e) 7 items (0\~10) for a reactive dimension; and (f) a body diagram for location of pain. The BPI-SF pain scores are determined by adding 4 items on the intensity of pain and 7 items on the interference of pain (0\~110; no pain to extreme pain).

  • Activity monitoring device (Fitbit) as a tool for digital pain biomarkersPretest, Post 1-month, Post 3-months

    * Records continuous, automatic, wrist-based resting heart rates, total steps and time (physical activity), and non-walking activities (e.g., swim duration and pool lengths). * Has an auto sleep tracking function and records the duration of sleep, sleep stage, and number of times waking. Data on the time asleep and number of wakes will be measured and the time asleep (the overall tracked time - the time awake/restless) will be calculated. * The data on resting heart rates, total steps and time (physical activity), and time asleep will be used for data analyses to address the specific aims.

  • Memorial Symptom Assessment Scale-Short Form (MSAS-SF)Pretest, Post 1-month, Post 3-months

    * 26 items on symptoms experienced during the past 7 days. * Rated on a 5-point (0-4) Likert scale; (0=no symptom to 4=very much). * Includes the Global Distress Index (4 psychologic and 6 physical symptoms), the physical symptom distress score (12 items), the psychologic symptom distress score (6 items), the total symptom distress, and the number of total symptoms. * Determines the MSAS-SF scores by adding the ratings for distress of 26 symptoms.

  • Center for Epidemiologic Studies Depression Scale (CES-D)Pretest, Post 1-month, Post 3-months

    * Measures the frequency of depressive symptoms in the past week. * 20 items on the level of depression (range=0\~60). All items are summed to calculate depressive symptoms score

  • Functional Assessment of Cancer Therapy Scale-Breast Cancer (FACT-B)Pretest, Post 1-month, Post 3-months

    * 44-items to measure multidimensional quality of life in patients with breast cancer. * Consists of the FACT-General plus the Breast Cancer Subscale (BCS), which complements the general scale with items specific to quality of life. * 7 domains: physical well-being, social/family well-being, emotional well-being, functional well-being, relationship with doctor, BCS, and additional concerns. * On a 5-point Likert scale (0=not at all\~4=very much), indicating a range of non to extreme interference. All items are summed to obtain a total score (FACT-B score).